Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?

Cancer medicine - 1 Jul 2017

Bender Carolin, Enk Alexander, Gutzmer Ralf, Hassel Jessica C

Abstract excerpt

Uveal melanomas (UMs) are a rare form of cancer with clinical and pathological characteristics distinct from cutaneous melanomas. Ipilimumab has shown efficacy and safety in the treatment of metastatic UM. This provides a rationale for treatment with other immune checkpoint inhibitors. This is a retrospective review of 15 patients with metastatic UM treated between June 2014 and February 2016, who received...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antineoplastic Agents, Immunological
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Programmed Cell Death 1 Receptor

Share to Uveal Melanoma

Share to Uveal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 28639409
DOI: 10.1002/cam4.887
PMCID: PMC5504332

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?PMID 28639409Read ↗

Update on Metastatic Uveal Melanoma: Progress and Challenges.Semantic proximity Read ↗

Overview of disease pathology and discussion advancements in immunotherapy for the treatment of uveal melanomaSemantic proximity Read ↗

Uveal melanoma: From diagnosis to treatment and the science in between.Semantic proximity Read ↗

Metastatic uveal melanoma: biology and emerging treatments.Semantic proximity Read ↗

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitorsSemantic proximity Read ↗

Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.Semantic proximity Read ↗

Current molecular and clinical insights into uveal melanoma (Review).Semantic proximity Read ↗

A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.Semantic proximity Read ↗

Upcoming translational challenges for uveal melanoma.Semantic proximity Read ↗

Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistanceSemantic proximity Read ↗

How to Make Immunotherapy an Effective Therapeutic Choice for Uveal MelanomaSemantic proximity Read ↗

Metastatic melanoma: a regional review and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.